RNV
RENERVE FPO [RNV]
Healthcare · ASX Small Cap
$0.0920 +3.4%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical42
Catalyst52
Sentiment50
Fundamental46
Momentum68
Risk Gate42
Get alerts when RNV's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Above-average volume (1.5x) on a red day — sellers in control
- Drifting lower — down 7.1% over the last 5 days
- Low cash runway (4 quarters) - dilution risk
- Strong revenue growth (+60%)
- Near 52-week low (2% of range)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (2 events)
- Dilution velocity warning (2 raises recently)
- CANSLIM S: Tight float (49%)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +60% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (1.77%/day)
- Elevated dilution risk (2 recent capital raises)
- Beneish M-Score 4.88 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about RNV
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Cleansing Notice
NONE Application for quotation of securities - RNV
NONE Proposed issue of securities - RNV
LOW Half Year Investor Presentation
Recent ASX Announcements
| 2026-03-24 | Cleansing Notice |
| 2026-03-24 | Application for quotation of securities - RNV |
| 2026-03-23 | Proposed issue of securities - RNV |
| 2026-03-16 | Half Year Investor Presentation |
| 2026-03-09 | Half Year Investor Webinar |
Key Metrics
$15.9M
Market Cap
146K
Avg Volume
1.5x
Vol Ratio
$0.09 — $0.22
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-74.9%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 49% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #110 of 117 · Sector avg: 46
View all Healthcare signals →Track RNV and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required